Strong sales reported for Sepracor's new insomnia drug

05/13/2005 | Wall Street Journal, The

Sepracor's new insomnia drug, Lunesta, has gotten off to a fast start in the market and appears to be cutting into sales of Sanofi-Aventis' Ambien, currently the biggest-selling sleeping pill in the world. Market trackers report more than 150,000 prescriptions of Lunesta in its first month on the market, topping the openings of several widely used drugs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX